FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
METHOTREXATE | 70518-1398-4 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 70518-1398-3 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 68382-775-16 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 68382-775-60 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 0143-9517-01 | Hikma Pharmaceuticals USA Inc. | ANDA089342 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-012-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 70518-1398-5 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-020-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 68382-775-77 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-017-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 70771-1058-7 | Zydus Lifesciences Limited | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 70771-1058-1 | Zydus Lifesciences Limited | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 68382-775-01 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-017-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 0143-9519-10 | Hikma Pharmaceuticals USA Inc. | ANDA089340 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-012-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 70771-1058-2 | Zydus Lifesciences Limited | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 68382-775-10 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 0143-9830-01 | Hikma Pharmaceuticals USA Inc. | ANDA040632 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 70771-1058-3 | Zydus Lifesciences Limited | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-010-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 0143-9518-01 | Hikma Pharmaceuticals USA Inc. | ANDA089341 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 70518-1398-0 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-017-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-